Donovanosis treated with thiamphenicol.

Braz J Infect Dis

Department of Dermatology, School of Medicine, University of São Paulo, Brazil.

Published: August 2007

Ten patients with donovanosis were treated with thiamphenicol for two weeks. In eight of them, included two HIV infected patients, lesions healed. The safety profile of thiamphenicol makes it a useful and cost-effective agent in the management of donovanosis. Randomized controlled trials should be conducted with these treatment options.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s1413-86702007000400002DOI Listing

Publication Analysis

Top Keywords

donovanosis treated
8
treated thiamphenicol
8
thiamphenicol ten
4
ten patients
4
patients donovanosis
4
thiamphenicol weeks
4
weeks included
4
included hiv
4
hiv infected
4
infected patients
4

Similar Publications

A case report of donovanosis in HIV-positive female.

Indian J Sex Transm Dis AIDS

June 2024

Department of Dermatology and Venereology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

Donovanosis is a chronic granulomatous ulcerative sexually transmitted infection caused by Klebsiella (Calymmatobacterium) granulomatis. A 39-year-old female patient with underlying HIV infection presented to the department of dermatology outpatient department with a painless ulcer over the left labia majora for 3 months. Histopathological examination revealed histiocyte which contains granular material resembling coccobacilli and Giemsa staining was positive for Donovan bodies.

View Article and Find Full Text PDF
Article Synopsis
  • * Diagnostic tests revealed leukoplakia indicating donovanosis, while biopsy confirmed molluscum contagiosum, and blood tests were positive for HIV-1 and HSV-2.
  • * The patient was treated with acyclovir and doxycycline, alongside antiretroviral therapy, showing slow improvement over 8 weeks; the case highlights the importance of tissue smears in diagnosing granuloma inguinale in immunocompromised patients.
View Article and Find Full Text PDF
Article Synopsis
  • - The rise of sexually transmitted infections (STIs) in the tropics is increasingly concerning, especially after the 2022 emergence of monkeypox, which echoes the previous spread of HIV/AIDS globally.
  • - A World Health Organization (WHO) 2023 report highlights that STIs are on the rise worldwide, and antibiotic resistance is worsening, particularly for certain bacteria, while macrolide resistance has developed in the last two decades.
  • - The potential for neglected tropical diseases like Zika and Ebola to be sexually transmitted after recovery raises new discussions about the use of pre-exposure prophylaxis (PrEP), especially for migrants and in Africa.
View Article and Find Full Text PDF

An Ulcer by Any Other Name: Non-herpes and Non-syphilis Ulcerative Sexually Transmitted Infections.

Infect Dis Clin North Am

June 2023

Division of Infectious Diseases, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, THT 215, 1900 University Boulevard, Birmingham, AL 35294, USA.

Article Synopsis
  • Ulcerative sexually transmitted infections (STIs) present a diagnostic challenge due to similar symptoms and limited testing resources, excluding herpes and syphilis.
  • Despite a low prevalence and declining incidence of conditions like chancroid and granuloma inguinale, they still lead to significant health issues and higher HIV risk.
  • With new threats like mpox emerging, accurate identification and treatment of these STIs is crucial for public health.
View Article and Find Full Text PDF
Article Synopsis
  • - Donovanosis is a long-lasting sexually transmitted infection caused by the bacteria Klebsiella granulomatis, especially seen in individuals with HIV/AIDS.
  • - The case study discusses a patient with relapsing donovanosis who is on second-line antiretroviral therapy and experiences fluctuating CD4 counts, linked to the worsening and eventual improvement of the infection.
  • - Treatment was initially ineffective while the patient's CD4 count was low, but symptoms improved as the CD4 count recovered, highlighting the relationship between immune function and infection management.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!